Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564054 · ClinicalTrials.gov registry record · NA
Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03564054 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 3 participants.
The verdict
NCT03564054, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the efficacy of photodynamic therapy (PDT) in relieving airway obstruction in subjects with lung cancer compared to treatment with argon plasma coagulation (APC).
Interventions
- PROCEDURE Photodynamic Therapy
- PROCEDURE Argon Plasma Coagulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-10-11 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03564054
The ClinicalTrials.gov registry entry for NCT03564054 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Photodynamic Therapy is the first listed.
NCT03564054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03564054 about?
NCT03564054 is a clinical study titled "Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction". The purpose of the study is to assess the efficacy of photodynamic therapy (PDT) in relieving airway obstruction in subjects with lung cancer compared to treatment with argon plasma coagulation (APC).
What is the current status of trial NCT03564054?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2018-10-11. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT03564054?
The interventions under investigation include: Photodynamic Therapy (PROCEDURE), Argon Plasma Coagulation (PROCEDURE).
Who is sponsoring clinical trial NCT03564054?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.